This study describes a new dual-injection, dual-temporal resolution (DTR) DCE-MRI mapping technique, which performs first-pass adjustment (FAD) of pre-bolus uptake curves using enhancement patterns measured from a main-dose, high-spatial resolution DCE acquisition. This new technique permits derivation of whole brain, super-spatial resolution kinetic parameter maps and its clinical applicability in vivo was assessed through application to retrospective DTR-DCE-MRI data from 12 NF2 patients undergoing Avastin therapy. Compared to the classical DTR-DCE-FDHS, method, baseline Ktrans derived using the FAD technique demonstrated superior ability in the prediction of 90 day volumetric response in Avastin treated NF2 related VS.